What did CDC pause testing for?

CDC temporarily halts testing amid staffing shortages

The CDC has temporarily paused testing for several infectious diseases after staffing shortages disrupted its support for state and local public health laboratories. The story describes the CDC’s normal role as providing testing capacity and technical support, and explains that the pause is tied to staff departures that have left the agency “hobbled.”

The coverage in the provided stories does not list every specific disease in the pause order. However, it does frame the change as a practical operational decision rather than a change in scientific priorities.

A separate item in the pool adds more detail that at least some testing removed from the CDC’s routine includes diseases that are especially important for outbreak monitoring. It explicitly mentions that the pause covers rabies and mpox testing. This matters because both are conditions where timely lab confirmation can affect containment efforts and public guidance.

Why it matters: when a national reference lab reduces testing availability, local jurisdictions may face longer turnaround times or increased pressure to use alternative workflows, private labs, or different reporting channels. That can slow detection and response during outbreaks, particularly in areas with fewer testing resources.

The common thread across the stories is the same:

• testing capacity is limited by staffing,
• local labs rely on CDC support for certain infectious disease diagnostics,
• and the pause could hinder early identification during the period of reduced support.

Public health agencies typically use these changes to triage—focusing limited lab capacity on the highest-urgency diagnostic needs—while they work to restore staffing and stabilize services.